XE-Bio From Park Systems Brings Promise in Fight Against Hepatitis C

Park Systems' XE-Bio helped researchers at Stanford University discover a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.

Related Posts

Comments are closed.